Identification of the clinical development candidate mrtx849, a covalent krasg12c inhibitor for the treatment of cancer Deposition Author(s): Smith, D.J. , Vigers, G.P.
Date: 2019-10-28 Method: X-RAY DIFFRACTION Resolution: 2.27 Å Organism(s): Homo Sapiens Sequences Data: 6USX_A , 6USX_B
Identification of the clinical development candidate mrtx849, a covalent krasg12c inhibitor for the treatment of cancer Deposition Author(s): Smith, D.J. , Vigers, G.P.
Date: 2019-10-28 Method: X-RAY DIFFRACTION Resolution: 2.03 Å Organism(s): Homo Sapiens Sequences Data: 6USZ_A
Identification of the clinical development candidate mrtx849, a covalent krasg12c inhibitor for the treatment of cancer Deposition Author(s): Smith, D.J. , Vigers, G.P.
Date: 2019-10-29 Method: X-RAY DIFFRACTION Resolution: 1.94 Å Organism(s): Homo Sapiens Sequences Data: 6UT0_A , 6UT0_B , 6UT0_C , 6UT0_D